πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 83 of 200 Β· A–Z by INN

  1. garenoxacin mesilate hydrate

    GENINAX

    PMDA: approved

  2. garenoxacin mesylate

    GARENOXACIN MESYLATE

    EMA: application withdrawn

  3. gatifloxacin

    GATIFLOXACIN

    OPHTHALMIC FDA: approved

  4. gb06

    NMPA: clinical trials

  5. gb221

    NMPA: clinical trials

  6. gbp510

    SKYCOVION

    EMA: application withdrawn

    J07BX03
  7. gefapixant

    LYFNUA

    EMA: approved

    R05DB29
  8. gefapixant citrate

    LYFNUA

    PMDA: approved

  9. gefitinib

    CIPLA GEFITINIB Cipla Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01XE02
  10. gemcitabine

    DBL GEMCITABINE INJECTION Pfizer Australia Pty Ltd

    INJECTION FDA: approved Β· TGA: approved Β· NMPA: clinical trials

  11. gemcitabine hydrochloride

    GEMCITABINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  12. gemfibrozil

    LOPID Teva Pharma GmbH

    ORAL FDA: approved

  13. gemfibrozil product

    AUSGEM Alphapharm Pty Ltd

    TGA: approved

  14. gemifloxacin mesylate

    GEMIFLOXACIN MESYLATE

    ORAL FDA: approved

  15. gemtuzumab ozogamicin

    MYLOTARG Pfizer Australia Pty Ltd

    SINGLE-DOSE FDA: approved Β· EMA: approved Β· TGA: approved

    L01XC05
  16. gentamicin sulfate

    GENTAMICIN SULFATE Teva Pharma GmbH

    OPHTHALMIC FDA: approved

  17. gentian alkaline mixture

    NULL

    TGA: approved

  18. gentian violet

    GVS

    VAGINAL FDA: approved

  19. gentuximab

    NMPA: clinical trials

  20. gepirone hydrochloride

    EXXUA

    ORAL FDA: approved

  21. gepotidacin mesylate

    BLUJEPA

    ORAL FDA: approved

  22. germanium (68ge) chloride

    GALENVITA

    EMA: approved

    V09X
  23. gilteritinib

    XOSPATA Astellas Pharma Inc

    EMA: approved Β· TGA: approved

    L01EX13
  24. gilteritinib fumarate

    XOSPATA

    ORAL FDA: approved Β· PMDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources